Alemtuzumab: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz (New page: {{subpages}} <!-- Text is transcluded from the BASEPAGENAME/Definition subpage-->) |
(No difference)
|
Latest revision as of 15:14, 18 January 2010
Alemtuzumab [r]: A antineoplastic agent, of the monoclonal antibody class, directed against the CDw52 antigen expressed by lymphocytes [e]
This article contains just a definition and optionally other subpages (such as a list of related articles), but no metadata. Create the metadata page if you want to expand this into a full article.